SCHEMBL4264656

SCHEMBL4264656

O=C(O)C(CC(=O)C1(c2cccc3c2oc2ccccc23)C=CC(c2ccccc2)=CC1)Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.35
CCR2 P41597 1/20 0.35
PTPRC P08575 1/20 0.34
PTPN2 P17706 1/20 0.34
PTPN1 P18031 1/20 0.34
PTPN6 P29350 1/20 0.34
PTPN9 P43378 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN11 Q06124 1/20 0.34
PTPN22 Q9Y2R2 1/20 0.34
PPARG P37231 1/20 0.34
CPA1 P15085 1/20 0.33
MME P08473 7/20 0.33
GPR52 Q9Y2T5 1/20 0.33
ECE1 P42892 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ACP3 P15309 2/20 0.32
IDO1 P14902 1/20 0.32
STAT3 P40763 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4264653 0.77 PPARA (0.35) PPARACCR2PTPRCPTPN2PTPN1
SCHEMBL5768014 0.77 PTPN1 (0.40) PTPN1DUSP3CPA1MME
SCHEMBL5740879 0.74 PTPN2 (0.36) PTPRCPTPN2PTPN1PTPN6PTPN9
SCHEMBL4269557 0.72 GGPS1 (0.41) PPARAPPARGCPA1GPR52MEN1
SCHEMBL4265412 0.71 GGPS1 (0.41) PPARAPPARGCPA1GPR52MEN1
SCHEMBL4274375 0.71 ADAMTS4 (0.36) PTPN1DUSP3MME
SCHEMBL4267609 0.66 PTPN1 (0.47) PTPN1DUSP3
SCHEMBL3961471 0.65 FOLH1 (0.62) PPARAPPARGCPA1MEN1KMT2A
SCHEMBL3961475 0.65 FOLH1 (0.62) PPARAPPARGCPA1MEN1KMT2A
SCHEMBL3961470 0.65 FOLH1 (0.62) PPARAPPARGCPA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082392-A1 Substituted Carboxylic Acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC 2009-03-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082392-A1 Substituted Carboxylic Acids PTPRJ, PTPRS, PTPRG PPARA 413/4885CCR2 2545/4885PTPRC 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.